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Abstract.  Mammary explants from 14-15-d-pregnant 
mice synthesize and secrete milk proteins in culture in 
response to insulin, hydrocortisone, and prolactin. 
Here we demonstrate that transforming growth factor 
B (TGF/$) treatment suppresses, in a dose dependent 
and reversible manner, the ability of explants to syn- 
thesize and secrete milk caseins. TGF~ does not affect 
the level of casein mRNA within explants but inhibits 
casein synthesis posttranscriptionally. We also show 
increased expression of TGF/32 and TGF/33 in intact 
mammary gland as pregnancy progresses, with reduced 
expression of all three TGF/3s at the onset of lactation. 
These findings suggest that endogenously produced 
TGF/~ may limit the accumulation of milk caseins that 
are produced in the mammary gland during pregnancy. 
T 
HIS paper describes a potential  role for locally pro- 
duced transforming  growth factor beta  (TGFB)  ~ in 
limiting  the  accumulation of milk proteins  in  the 
mouse mammary gland during pregnancy. Previous results 
from our laboratory demonstrated abundant  expression of 
TGFB2 and TGF/~3 transcripts  in the mammary glands of 
pregnant mice, but very low levels of expression of all three 
mammalian TGFBs in the glands of lactating mice. We also 
showed that none of the TGF/~s alter normal alveolar growth 
and morphogenesis  when administered to  the mammary 
glands of  pregnant mice using miniature slow-release plastic 
implants (Daniel et al., 1989; Robinson et al., 1991). These 
findings suggested that TGFBs might play a role in preparing 
the gland for lactation.  We investigated this possibility  by 
treating cultured mammary explants from 14-15-d-pregnant 
mice with TGFB and lactational  hormones. 
Milk  proteins  are  classified  into  the  acid-precipitable 
caseins and the whey proteins.  The caseins are a family of 
milk phosphoproteins  whose biological  function is to pro- 
vide supersaturating concentrations of calcium, phosphates, 
and essential  amino acids to the neonate (Vandahaar and 
Ziska,  1989). ~  and ~-caseins,  the most abundant of the 
milk caseins, are described as calcium sensitive because they 
precipitate in the presence of low concentrations of calcium 
(Wangh, 1971). They are maintained in stable suspension in 
milk because of their interaction with x-casein (Mackirday 
and Wake, 1971). Their relative abundance in milk makes 
caseins ideal markers of differentiated mammary function. 
1. Abbreviation used in this paper:  TGE transforming growth factor. 
The regulation of casein synthesis and secretion is a com- 
plex process regulated by multiple interactions between pep- 
tide and steroid hormones (Topper, 1970; Topper and Free- 
man, 1980). Whole mammary organs or mammary explants 
synthesize and secrete milk proteins in the presence of the 
lactogenic hormones insulin, prolactin,  and hydrocortisone 
(Elias,  1957; Jeurgens et al.,  1965; Forsyth,  1971; Rivera, 
1971). Expression of caseins in culture is also influenced by 
cell-cell and cell-matrix interactions  (Levine and Stock- 
dale,  1985; Bissell and Ram,  1989), and there is now in- 
creasing evidence that growth factors,  such as EGF, TGE 
fibroblast growth factors, and insulin-like growth factor play 
important roles in mammary  growth and differentiation (Oka 
et al.,  1991). TGF/31 inhibits the expression of B-casein in 
lactogenic hormone-induced  HC11 mouse mammary  epithe- 
lial ceils (Mieth et al.,  1990). Here, we show that all three 
TGF~s regulate mammary explant production of caseins by 
suppressing their synthesis and subsequent secretion. 
We also expand our previous analysis of TGF/~ mammary 
mRNA expression patterns during pregnancy and lactation. 
TGF/Y2 and TGF/$3 levels increase as pregnancy continues, 
with greatly reduced expression  of all three TGFBs after 
birth.  These findings suggest that TGF/~ may help limit the 
accumulation of milk caseins during pregnancy and that its 
own expression may be regulated by the hormones of preg- 
nancy and lactation. 
Materials and Methods 
Explant Cultures 
14-15-d-pregnant, prirniparous, Balb/C mice were anesthetized with Nero- 
￿9  The Rockefeller  University  Press, 0021-9525/93/01/245/7  $2.00 
The Journal of  Cell Biology, Volume 120, Number 1, January 1993 245-251  245 butal (60 ~g/g body weight) and the number three thoracic and number four 
inguinal  mmmnary  glands  were  removed  aseptically  and  rinsed  in 
DME/F12 medium containing 5/~g/mi gentamycin sulfate. The tissue was 
removed to a sterile surface and minced with sterile stainless steel razor 
blades. A number of explants, weighing a total of 30-100 rag, were trans- 
ferred to a 15-mi conical culture  tube  containing the appropriate medium. 
Cultures  were gassed briefly with 5% CO2:95% air, sealed tightly, then 
placed at 37~  on a rotary shaker at 300 rpm. Medium was replaced every 
48 h (Western blot analysis and characterization  studies) or every 24 h (all 
other experiments). The glands from two or more animals were used in all 
studies. Lactogenlc hormones were 5 ~g/mi each of insulin (Sigma Chemi- 
cal Co., St. Louis, MO), hydrocortisone (Sigma Chemical Co.), and prolac- 
tin (National Institutes of Health).  Aldosterone  (Sigma Chemical Co.) at 
5/~g/ml was also included in the culture medium (see Ganguly et al., 1981). 
We are defining secreted proteins as those that can be detected in culture 
medium.  The bulk of secretion in explants is directed toward the lumens 
which have been cut by dissection of  the explants. Shaking the explants dur- 
ing the culture period, which served to prevent the explant lumens from be- 
coming clogged with secreted proteins, was critical for the continuous re- 
lease of proteins into the medium. 
RNA Preparation 
Tissues or explants were frozen in liquid nitrogen immediately after removal 
from the animal or from culture media and total RNA was prepared as pre- 
viously described (Robinson et al., 1991). FOr tissues, total RNA was iso- 
lated from 2-6 animals for each stage examined. 
Northern Hybridization 
RNA was electrophoresed in 1.0% agarose containing 2.3 M formaldehyde 
in MOPS buffer (0.2 M morpholinopropane sulphonlc acid, 50 raM sodium 
acetate, 5.0 mM EDTA. pH 7.0). RNA was transferred to Magna NT (MSI, 
Inc., Westboro, IdA) by the established procedure of  Maniatis ct al. (1982). 
The RNA was hybridized,  under  high  stringency  conditions,  to mouse 
cDNA probes radiolabcled with 32p by random priming.  Washes after the 
hybridizations were in 0.1￿  SSPE/0.1% SDS  at 65~  18 S rRNA was de- 
tected with a complementary  18-base oligonucleotide end-labeled with ;2p. 
Here,  washes were in 2x  SSPE/0.1% SDS at 57~ 
TGF~ clones were provided by P. Kondaiah (Laboratory  of Chemopre- 
vention, Bethesda, MD). Casein clones, provided by M. Bissell (Lawrence 
Berkeley Laboratory,  Berkeley, CA), were originally isolated by J. Rosen 
(Baylor College of Medicine, Houston,  TX). The 18 S rRNA oligonucleo- 
tide was provided by H. Noller (University of Califorula, Santa Cruz, CA). 
Immunoblot Analysls 
To detect caseins in culture medium,  1-mi  samples were precipitated with 
a final concentration of 10% "I~.A. Protein pellets were resuspended in elec- 
trophoresis  sample buffer (2% SDS,  10% glycerol, 0.08 M Tris-HC1, pH 
~8, 2 mM EDTA, 0.1 M DTT, 0.01% bromophenol blue) and denatured at 
95~  for 10 min before loading onto 13 % denaturing acrylamide gels. Sam- 
ple loading was standardized on the basis of total 1~A-precipitable  counts 
present in the ~  "nginal sample. After eloctrophoresis,  proteins were trans- 
ferred to Immobilon P membrane (Millipore Co., Medford, MA) in 25 mM 
Tris-bnse,  192 mM glycine,  15%  (vol/vol)  methanol.  Membranes  were 
blocked for 2 h at 37~  with 5% BSA (Sigma Chemical Co.) in 20 mM 
Tris-HCl, pH 7.5, 500 ram NaC1 CI'BS). The blots were then washed 3  x 
5 rain in 0.1% BSA in TBS. The membranes were incubated for 1 h in poly- 
clonal rabbit anti-mouse milk casein antiserum (diluted 1:3,000 in 1% BSA, 
0.05 % Tween-20 in TBS) and washed as above. Bound antibody was de- 
tected by addition of HRP-cunjngated anti-rabbit IgG (Bio-Rad Laborato- 
ries,  Richmond,  CA),  followed  by  4-r  and  H202.  All 
washes  and  antiserum  incubations  were  at  ambient  temperature.  Bi- 
otinylated  size markers  were detected  with HRP-conjngated  streptavidin 
(Bio-Rad Laboratories).  The rabbit anti-mouse casein antiserum was a gift 
from Victor Rocba (University of California,  Santa Cruz, CA). 
Metabolic 35S-labeling 
FOr Western blot, dose-dependence,  and characterization  studies, explants 
were incubated  during  the final 24 h of culture  in 4.5 ml of DME/FI2 
medium to which 100 ~Ci of [3SS]methionine from translabel (ICN, 1200 
Ci/mmol) was added. The medium was harvested and stored at -70~  until 
immunoprocipitation.  FOr pulso-chase  studies explants were cultured for 
4 d. During the final hours of culture, medium was replaced with 1 mi of 
methionlne-free  DME/F12  and 250 ~tCi of [35S]methionlne  (Amersbam 
Corp.,  Arlington  Heights,  IL) (1200  Ci/mmol) was  added.  For  pulse  only 
studies,  labeling  was stopped  by quick  freezing,  and explants  were stored 
at  -70~  until  further  analysis.  For  pulse-chase  studies,  I  h  of  labeling  was 
followed by rinsing in ice-cold DME/F12 containing an excess of unlabeled 
methionine (4 mg/mi). The explants were then incubated in 1.5 ml of the 
same methionine-rich medium for varying amounts of time and processed 
for further  analysis as described  above. 
Immunoprecipitation 
Media  fractions  were  adjusted  in  1.0  mi  to  radioimmunoprecipitation 
(RIPA) buffer conditions (50 mM Tris-HC1, pH 7.4, 150 mM NaC1, 5 mM 
Na2EDTA, 2 mM phenylmathylsulfonyl fluoride,  1/~g/mi aprotinln,  0.1% 
SDS, 0.2%  NP-40,  and 0.5%  sodium deoxycholate).  The explants were 
homogenized in 1.5 ml of RIPA buffer without detergents and immunopre- 
cipitation was conducted by adjusting these samples in 0.5 ml to RIPA deter- 
gent concentrations. The total incorporation of radioactivity was calculated 
from the TCA-precipitable counts contained  in the medium  and  explant 
homogenate samples and aliquots representing equal numbers of total TCA- 
precipitable epms were used for immonoprecipitation.  RIPA-adjusted sam- 
ples were incubated for 45 rain at 4~  with anti-casein antiserum and subse- 
quently for 1 h with 0.1 vol of 10%  (wt/vol) protein  A-sepharose  beads 
(Pharmacia,  Milwaukee, WI). The protein  A-Sepharose  beads  were col- 
lected by centrifugetion,  and washed (3￿  RIPA buffer;  l￿  50 raM Tris- 
HC1, pH 7.4) for 20 rain with end-over-end rotation at 4~  The precipitated 
proteins were eluted in electrophoresis sample buffer by heating at 95~  for 
10 rain and then separated by electrophoresis in denaturing 13 % acrylamide 
gels. For fluorography, gels were treated for 30 rain with Amplify (Amer- 
sham Corp.),  dried,  and exposed at  -70~  to x-ray film. 
Results 
TGF~ mRNA Levels during Pregnancy  and Lactation 
We previously showed (Robinson  et al.,  1991)  that steady- 
state mRNA  levels for TGF/~2  and  TGF~3  are high in the 
Figure 1. Expression of TGF~ mRNAs during pregnancy and early 
lactation. Blots containing total RNA (15 ttg per lane) isolated from 
mammary glands of virgin, pregnant,  and lactating animals were 
hybridized to radiolabeled,  isoform-specific TGFI5 cDNA probes 
and washed under conditions of high stringency (0.1  x  SSPE, 0.1% 
SDS, 65~  To control for equivalent loading of  the mRNA, rRNA 
was examined by UV shadowing after electrophoresis (the positions 
of 28 S and 18 S ribosomal RNAs are indicated for reference). As 
a control for equivalent transfer and integrity of the samples, the 
blots were later probed for the expression of 18 S ribosomal RNA 
(lower panels).  Lanes:  (1) virgin; (2) 6 d  pregnant; (3) 9 d  preg- 
nant; (4)  12 d pregnant; (5)  15 d pregnant; (6)  17 d pregnant; (7) 
day of birth;  (8) 3  d  after birth. 
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tion.  Here, we performed a  more detailed analysis of the 
mammary gland expression patterns of TGFfll, TGFB2, and 
TGF/33 mRNAs during pregnancy and early lactation. RNA 
was isolated from mammary glands of virgin, staged preg- 
nant, and early lactating animals and RNA blots were probed 
with radiolabeled TGFB cDNAs (Fig.  1). 
TGFB1 transcript levels did not change significantly dur- 
ing pregnancy and lactation,  with the  exception of slight 
decreases at 17 d of pregnancy and 3 d after birth. TGFB2 
and TGFB3 mRNA levels, on the other hand, increased dur- 
ing pregnancy, with peak expression at 15 d. The levels de- 
creased transiently at 17 d of pregnancy and decreased again 
3 d after birth. We previously showed that the levels of all 
three TGF/3 transcripts are low after seven days of lactation 
(Robinson et al.,  1991). 
The temporal variation of TGFB mRNA levels between 
pregnancy and lactation suggested that the loss of TGFB ex- 
pression is necessary for the onset of lactation. 
TGFB Suppresses Casein Secretion 
Mammary  explants  were  isolated  from mouse mammary 
glands at  14 d of pregnancy as described in Materials and 
Methods.  The nature of secreted milk caseins  was  deter- 
mined by Western blot analysis of the medium from explants 
which were cultured for four days in the presence of lacto- 
genie hormones alone,  or in  lactogenic hormones plus  5 
ng/ml of TGFB1, TGF/~2,  or TGF/33. 
The positions of o~l-casein (43 kD),  ~x2-casein (39 kD), 
B-caseins (26 kD), and v-casein (23.7 kD) in mouse milk are 
indicated in lane 6 of Fig. 2 A and are consistent with those 
reported by Hennighausen and Sippel (1982). "y-casein is not 
as abundant as the other caseins and was not readily detected 
in most of our assays.  Medium from explants cultured in the 
absence of lactogenic hormones was analyzed as a control 
for antiserum specificity and is shown in lane I  of Fig. 2 A. 
The levels of secreted caseins were high in the medium from 
explants cultured in lactogenic hormones (lane 2). With the 
addition of TGFB,  casein  secretion was dramatically sup- 
pressed (lanes 3, 4, and 5). As shown in lane 5, suppression 
of casein secretion was always greatest with TGF~3. For this 
reason, and because the response was similar with all three 
TGF/3s, further discussion will focus on the results we ob- 
tained with TGF/53. 
Explants were labeled with 35S-translabel during the final 
24 h of culture and for gel loading, individual medium sam- 
pies were standardized on the basis of  total TCA-precipitable 
counts. To determine whether TGFB selectively suppressed 
casein secretion the transfer membrane was exposed to x-ray 
film following Western blot analysis (Fig. 2 B). The medium 
pattern of total,  35S-labeled  proteins  was  identical in  the 
presence or absence of TGFB.  Determination of the total 
counts incorporated into "lV_A-precipitable proteins in both 
explants and medium indicated that the cells of the explants 
secreted ,o10% of total protein synthesized. This ratio was 
not changed as a result of TGFB treatment, providing further 
support for the selectivity of the response. 
Dose Dependence of the TGFB  Response 
The  dose  dependence  of  TGFB-induced  suppression  of 
casein secretion was examined in explants which were cul- 
Figure 2. Western blot analysis of caseins in the medium of explant 
cultures. Explants were cultured in the presence (+) or absence (-) 
of lactogenic hormones for 4 d. TGFB1 (lane 3), TGFB2 (lane 4), 
or "I'GF/33 (lane 5)  was included in the  indicated cultures at a 
concentration  of  5  ng/ml.  Cultures  were  labeled  with  35S- 
translabel  during  the  final 24  h.  (,4) A  blot  containing  TCA- 
precipitable proteins from media samples incubated with a rabbit 
polyclonai antiserum directed against milk caseins. Loading was 
standardized on the basis of total "lW-.A-precipitable  counts present 
in the media samples. Mouse milk (lane 6) was used as a control 
(20 #1 of a 1:30,000  dilution in electrophoresis sample buffer). Mo- 
lecular weight standards (kD) are indicated to the left of the figure. 
(B) Autoradiograph of the same blot to illustrate total 35S-labeled 
proteins present in the media samples. 
tured for 4 d in lactogenic hormones plus varying concentra- 
tions of TGFB3.  Cultures were labeled with 35S-translabel 
during the final 24 h  of culture and the levels of secreted 
caseins were detected in media samples by immunoprecipi- 
tation.  Fig.  3 A shows  a  representative example of the in- 
creased suppression of casein secretion that occurred with 
increasing concentrations of TGFB3. 
Robinson et al. TGF[3 Regulates Casein Symhesis  247 Figure 4. Characterization of 
TGFfl-induced suppression of 
casein  secretion.  Explants 
were cultured for 8 d and 35S- 
translabel was added to each 
culture during the final 24 h. 
Media samples were immuno- 
precipitated  with  anti-casein 
antiserum. Lanes (also repre- 
sented  diagrammatically  at 
the bottom of the figure): (1) 
lactogenic  hormones  alone 
throughout the 8-d culture; (2) 
lactogenie  hormones  plus 
TGFfl3 (5 ng/ml) for the first 
4 d of  culture, followed  by lac- 
togenic hormones alone for the remaining 4 d of culture; (3) lacto- 
genie hormones plus TGFfl3 (5 ng/ml) throughout the 8 d of cul- 
ture; and (4) lactogenic hormones alone for the first 4 d of culture 
followed by lactogenic hormones plus TGFfl3 (5 ng/ml) for the re- 
maining 4 d of culture. The fluorogram was obtained after 5 d of 
exposure to x-ray film. Molecular weight standards (kD) are indi- 
cated to the left of the figure. (n) Lactogenic hormones present; 
(m) TGF-fl present. 
Figure ~ Dose  dependence of the TGFfl response. Explants were 
cultured in the presence of lactogenic hormones and increasing 
amounts of TGFfl3 for 4 d. Cultures were labeled with 35S-trans- 
label during the final 24 h. (,4) Media samples were immunopre- 
cipitated with anti-casein antiserum and electrophoresed on a 13 % 
acrylamide gel. The fluorogram was obtained after 7 d of exposure 
to x-ray film. Molecular weight markers (kD) are indicated to the 
left of the figure. (B) A graphical representation of the data in A. 
The fluorogram was quantitated using a scanning densitometer and 
values obtained for the bands representing ,t-casein (X), c~2-casein 
(zx), and t-casein (u) at each dose of TGFfl3 and plotted as a per- 
centage of  the level of  casein present in the absence of any TGFfl3. 
Fig. 3 B is a graphical representation of the data in Fig. 
3 A. The exposed fluorogram shown in Fig. 3 A was quan- 
tiffed using  a  scanning  densitometer (Hoeffer, San  Fran- 
cisco, CA). Values obtained for the bands representing oh- 
casein,  o~2-casein, and  t-casein  at  each dose  of TGFfl3 
were plotted as percentages against the respective values in 
the absence of TGFfl3. Doses of TGFfl3 as low as 0.1 ng/ml 
led to the suppression of  casein secretion; 5 ng/ml and higher 
concentrations of TGFfl3 gave nearly complete suppression. 
The graph  indicates  similar  dose response curves for all 
three of the caseins examined. 
Characterization  of  the TGFfl Effect 
The response of explants to TGFfl was examined in greater 
detail by culturing explants for eight days in various combi- 
nations of laetogenic hormones and TGFfl3. 3sS-translabel 
was  added  during  the  final 24 h  of culture and  secreted 
caseins were analyzed by immunoprecipitation. 
Lane 2 of Fig. 4 shows the levels of secreted caseins from 
explants cultured for  4 d in laetogenic hormones plus 5 ng/rnl 
TGFfl3, followed by 4 d of culture in lactogenic hormones 
alone.  The secreted casein  levels approached  those  seen 
from explants cultured in lactogenic hormones alone for the 
entire 8  d  (lane/),  demonstrating that the suppression of 
casein secretion was reversible upon removal of TGFfl from 
the system. When TGFfl3 was present throughout the 8-d 
culture period, secreted casein levels were very low (lane 3). 
Since secretion is fully suppressed after 4 d in culture (Figs. 
2 and 3), continued suppression over four additional days of 
treatment indicated that the explants did not become refrac- 
tory  to  extended TGFfl treatment.  If cultures  were  first 
treated for 4 d with lactogenie hormones alone, followed by 
4  d  of treatment with lactogenic hormones plus  TGFfl3, 
casein secretion was still  suppressed  (lane 4),  illustrating 
TGFffs ability to  suppress  already-established casein  se- 
cretion. 
Casein Transcript Levels in TGFfl-treated Explants 
The effects of  TGFfl isoforms on casein gene expression were 
investigated by isolating total RNA from explants cultured 
for 48 h in the presence of  lactogenic hormones, either alone 
or with the addition of 5 ng/ml TGF~, TGFff2, or TGFfl3. 
In COMMA-D cells (Eisenstein and Rosen, 1988) and in rat 
manmmT organ cultures (Guyette et al.,  1979), t-casein 
mRNA accumulates for up to 48 h in the presence of laeto- 
genie hormones. For this reason, and because casein secre- 
tion in our explants is fully suppressed after 48 h of TGFfl 
treatment (not shown), we chose this time of treatment feel- 
ing it would offer the best opportunity of detecting differ- 
ences in casein transcript accumulation. 
RNA blots containing 5 #g of total RNA per lane were 
probed  with  a  radiolabeled  u-casein  or  t-casein  eDNA 
clone. TGF~I, TGFff3, or TGFff2 treatment (Fig. 5, lanes 5, 
6, and 7, respectively) had no effect on the accumulation of 
The Journal of Cell Biology,  Volume 120,  1993  248 Figure 5. Expression of  casein mRNAs in mammary explants. Blots 
containing total RNA (5 #g per lane) isolated from either explants 
or  mammary  glands were  hybridized  to  radiolabeled  c~-casein 
cDNA or t-casein cDNA and washed under conditions of high 
stringency (0.1 ￿  SSPE,  0.1% SDS, 65~  To control for equiva- 
lent loading of the mRNA, rRNA was examined by UV shadowing 
following electrophoresis. As a control for equivalent transfer and 
integrity of the samples, the blots were later probed for the expres- 
sion of 18 S ribosomal RNA (lower panels). Lanes: (1) virgin mam- 
mary gland; (2) 3-d lactating mammary gland; (3) explants cul- 
tured in the absence of lactogenic hormones; (4) explants cultured 
in lactogenic hormones alone; (5) explants cultured in lactogenic 
hormones plus 5 ng/ml TGFfll; (6) explants cultured in lactngenic 
hormones plus 5 ng/ml TGFfl3; and (7) explants cultured in lacto- 
genic hormones plus 5 ng/ml TGFfl2. 
a-casein or t-casein transcripts in explants; transcript levels 
were identical to those seen in explants treated with lacto- 
genic hormones alone (lane 4). The low levels of  casein tran- 
scripts present in the absence of lactogenic hormones (lane 
3) or in mammary tissue from virgin mice (lane/) and the 
high levels seen in lactating tissue (lane 2) are shown for ref- 
erence, ot~- and ot2-caseins are produced from transcripts of 
identical size (Hennighausen and Sippel,  1982). 
Kinetics of Casein Synthesis and Secretion in Explants 
The kinetics of casein synthesis and  secretion within cul- 
tured explants were analyzed by pulse-chase labeling (Fig. 
6).  Casein  levels  within  explant  homogenates and  media 
samples were evaluated by immunoprecipitation. 
The rate of casein synthesis in explants was analyzed by 
terminating the incorporation of  label into explants at 15-min 
intervals during  a  1-h pulse  (Fig.  6,  left panels).  TGFfl- 
treated explants synthesized caseins at a lower rate than un- 
treated, as indicated by lower casein levels in TGFfl-treated 
explants at all time points examined. 
For chase studies, explants were labeled with [35S]methi- 
onine for 1 h (over which time they secrete little labeled pro- 
tein  [not shown]),  washed with ice-cold buffer, and  then 
incubated in label-free medium. In untreated explants, incor- 
poration of label into caseins continued during the first hour 
of chase and over the next 4 h the amount of label decreased 
Figure 6.  Pulse-chase  analysis of casein  processing  in  TGFfl 
treated and untreated explants. Explants were cultured for a total 
of 4 d in the presence of lactogenic hormones or lactogenic hor- 
mones plus 10 ng/ml TGFfl3 and pulse-chased dul~ the final 6 h 
of culture. Medium and explant homngenates were collected at the 
indicated times. Samples were normalized on the basis of'lV-A-pre- 
cipitable  counts and  immunoprecipitated  with  anti-casein  anti- 
serum.  Panels: (upper left) casein levels in homogenates of un- 
treated  explants after indicated pulse times;  (lower left) casein 
levels in homngenates of TGFfl3-treated explants after indicated 
pulse times; (upper middle) casein levels in homogenates of un- 
treated explants after a 1-h pulse and indicated chase times; (lower 
middle) casein levels in homogenates of  TGFB3-treated  explants af- 
ter a l-h pulse and indicated chase times; (upper  righO casein levels 
in medium samples of untreated explants after a 1-h pulse and indi- 
cated chase times; (lower right) casein levels in medium samples 
of TGFfl3-treated explants after a  1-h pulse and indicated chase 
times. Fluorograms were obtained after 3 d of exposure to x-ray 
film. The positions of molecular weight markers (kD) are shown 
to the left of the top and bottom panels. 
(Fig. 6, upper middle panel).  A similar pattern of label in- 
corporation and turnover was seen in TGFfl-treated explants 
(Fig. 6, lower middle panel). This pattern of  label incorpora- 
tion and intracellular casein turnover also occurs in rabbit 
mammary explants that have been grown in culture for 48 h 
(A1-Sarraj  et al.,  1979; Razooki Hasan et al.,  1982; O'Hare 
et al., 1986). By 5 h of chase, the intracellular casein levels 
were identical in  TGF/3-treated and  untreated  explants,  a 
finding that is  consistent with the overall level of caseins 
present in explants if they are labeled continuously for 24 h 
(data not shown). 
After  pulse  labeling,  untreated  explants  secreted  35S- 
labeled caseins within 1 h (Fig. 6, upper rightpanel); no fur- 
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ouly barely detectable in the medium of TGF~-treated  ex- 
plants  (Fig.  6, lower right panel).  Prolonged radiographic 
exposure,  however, indicated  a pattern of casein secretion 
identical  to that in untreated explants  (not shown). 
Discussion 
The regulation  of casein gene expression during pregnancy 
and lactation  is a complex process involving  a coordinated 
response at several levels. A variety of hormones are known 
to play  roles  in lactogenesis  during pregnancy,  and growth 
factors  are  now being implicated  as local  mediators of  hor- 
mortal function (reviewed in Oka et al., 1991). Here, we 
show that  TGF/3 may he one of  these local  mediators. All 
three  TGF~ isoforms  suppress  the  synthesis  and secretion  of 
caseins in mammary  explants  cultured  in the presence of 
lactation-inducing  hormones. 
"I'GF/~ inhibits the growth of many epithelial  cells grown 
in culture (Roberts and Spore, 1990), including  mammary 
epithelial  cells  derived  from  reduction  mammoplasties 
(Stampfer and Bartley, 1988; Valverius et al., 1989) and sev- 
eral transformed mammary epithelial cell lines (Dickson and 
Lippman,  1987).  In situ,  TGFtSs reversibly inhibit  ductal 
growth in the virgin mouse mammary gland (Silberstein and 
Daniel,  1987; Robinson et al.,  1991). However, in situ ad- 
ministration  of TGF/~ to the mammary glands from pregnant 
mice does not influence  alveolar morphogenesis or DNA 
synthesis in alveolar cells (Daniel et al., 1989; Robinson et 
al.,  1991). Nor does TGF/5 treatment influence the growth 
or morphology of explants in culture (not shown). For these 
reasons, we believe it unlikely that TGFffs effect on casein 
expression is a result of growth inhibition. 
We show the effect of TGF8 to be selective for caseins 
(Fig. 2), to be dose dependent (Fig. 3), and to be reversible 
(Fig.  4). In addition,  TGF8 can suppress the secretion of 
caseins after the processes of milk production and secretion 
have been fully established (Fig. 4, lane 4) and explants in 
culture do not become refractory to prolonged TGF/5 treat- 
ment (Fig. 4, lane 3). These data demonstrate that TGF/3 ex- 
hibits  many of the requirements  expected of a pregnancy- 
associated, natural inhibitor of casein expression. 
To ensure that explants maintained their full d~erentiated 
functional potential throughout the culture period, we ini- 
tially examined the effects of TGF/~ on the hormonal induc- 
tion of explants by measuring secreted caseins. However, the 
influence of TGF/5 on casein secretion appears to be linked 
to reduced intracellular  production of these milk proteins. 
Pulse-chase  analysis  shows  a  dramatic  reduction  in  the 
amount of caseins that are produced in the presence of TGF8 
(Fig. 6). These studies also show that the patterns of casein 
processing and turnover as well as the steady-state intracellu- 
lar accumulation of caseins are not altered by TGF~ treat- 
ment.  Therefore,  TGF/3 does not affect the ability of hor- 
monally  treated  explants  to  synthesize  and  store  casein 
proteins; rather, it appears that TGF8 limits the rate of casein 
synthesis which results in reduced secretion.  We have not, 
however, formally ruled out the possibility that TGF/5 also 
influences  the process of casein secretion. 
We have not determined the exact point at which TGF/3 
suppresses casein synthesis. In contrast to the effects of EGF 
or TGFc~ on casein expression in HCll cells (Hynes et al., 
1990), ~F~-mediated suppression is not a result of reduced 
casein transcript accumulation.  Fig. 5 shows that there is no 
detectable difference in the overall levels of ~- and 13-casein 
transcripts  in hormonally treated explants after TGFf3 treat- 
ment.  TGFI3 could, however, influence casein synthesis by 
reducing the efficiency of casein translation  from these tran- 
scripts. 
We have also shown that TGFff2 and TGFfl3 transcript lev- 
els increase as pregnancy continues, but that their expression 
drops off shortly after birth. The change in expression is not 
a result of TGFfi transcript dilution  at lactation;  we have 
demonstrated, immunohistochemically,  the same expression 
pattern at the level of TGF~ protein (Robinson et al., 1991). 
Endogenous  expression  of TGF~  during  pregnancy  may, 
therefore,  limit casein synthesis and secretion.  We envision 
a mechanism  whereby milk production is initiated  by the 
hormones of pregnancy, but is kept in check by local growth 
factor mediators, such as TGF~ whose expression  rises in 
response to the hormones of pregnancy.  Once lactation be- 
gins,  efficient  secretion  of milk  components  can  occur, 
casein synthesis need no longer be limited,  and TGF~ ex- 
pression decreases.  TGF~ has been detected in milk (D. 
Danielpour,  Laboratory  of  Chemoprevention,  Bethesda, 
MD, personal communication),  suggesting a possible auto- 
crine type of feedback regulation on milk production during 
pregnancy. 
The following questions now arise:  (a) What TGF/~ iso- 
forms are important to this proposed mechanism in the ani- 
mal? While TGF/51 affects casein synthesis within explants, 
its effects in the animal may not be as significant as those of 
TGF~2 and TGFI53. Unlike TGFff2 and TGF/~3, TGF/31 tran- 
script levels do not significantly  change during  pregnancy. 
(b) At what level within the cell is casein accumulation  sup- 
pressed? The controls exerted on casein gene expression  in 
explants and cell culture occur at both the transcriptional  and 
posttranscriptional  levels (Guyette et al.,  1979; Eisenstein 
and Rosen, 1988).  Secretion-coupled degradation  has also 
been described as a posttranslational  mechanism of casein 
gene regulation in mammary explants (O'Hare et al., 1986). 
However, we see no evidence for decreased casein transcript 
accumulation  (Fig. 5) or increased intracellular  casein turn- 
over in response to TGF~5 treatment (Fig. 6). (c) What fac- 
tors regulate TGFB expression during pregnancy  and lacta- 
tion7 Progesterone is a likely candidate because of its known 
role in limiting  lactogenesis and  secretion (Davis  et al., 
1972;  Assairi  et al.,  1974; Terada et al.,  1988).  (d) Are 
other milk proteins,  such as whey acidic protein and a-lac- 
talbumin, regulated  in the same fashion as caseins? Studies 
to address these questions are currently in progress in our 
laboratory. 
We would like to thank Lisa Elfring for critical review of the manuscript. 
This research was supported by Public Health Service grant HD 27845. 
Received for publication 5 August 1992 and in revised form 28 September 
1992. 
R~ferel,lt~$ 
Al-Sarraj, K., J, Newbury, D. A. White, and R. J. Mayer. 1979. Casein turn- 
over  in rabbit  mammary explants in organ  culture.  B/ochem. J.  182: 
837-845. 
Assairi, L., C. De,  louis, P. Gaye, L.-M. Houdebine,  M. Ollivier-Bousquet,  and 
R. Danamur. 1974. Inhibition by progesterone of the lacmgenic effect of 
The Journal of Cell Biology, Volume 120, 1993  250 prolactin in the pseudopreguant rabbit.  Biochem.  J.  144:245-252. 
Bissell, M. J., and T. G. Ram. 1989. Regulation of functional cytodifferentia- 
tion and histogenesis in mammary epithelial  cells: role of the extracellular 
matrix. Environ.  Health Perspect. 80:61-70. 
Daniel, C. W., G. B. Silberstein, K. Van Horn, P. Strickland, and S. Robinson. 
1989.  TGF/~l-induced inhibition of mouse ductal growth: developmental 
specificity  and characterization. Dev. Biol.  135:20-30. 
Davis, J. W., J. Wiikman-Coffelt, and C. L. Eddington. 1972.  The effect of 
progesterone on biosynthetic pathways in mammary tissue. Endocrinology. 
91:1011-1019. 
Dickson, R. B., and M. E. Lippman. 1987.  Estrogenic regulation of growth 
and polypeptide growth factor secretion in human  breast carcinoma. Endocr. 
Rev.  8:29-43. 
Eisenstein, R. S., and J. M. Rosen. 1988. Both cell substratum regulation and 
hormonal regulation of milk protein gene expression are exerted primarily 
at the posttranscriptional level. Mol.  Ceil, Biol.  8:3183-3190. 
Elias, J.  J.  1957.  Cultivation of adult mouse mammary gland in hormone- 
enriched synthetic medium. Science (Wash.  DC).  126:842-844. 
Forsyth, I. A. 1971. Organ culture techniques and the study of bormone effects 
on the mammary gland. J. Dairy Res.  3:419  4~A.. 
Ganguly, N., R. Ganguly, N. M. Mehta, L. R. Cramp, and M. R. Banerjee. 
1981.  Simultaneous occurrence of pregnancy-like lobuloalveolar morpho- 
genesis  and casein-gene  expression in a culture of  the whole mammary  gland. 
In Vitro  (Rockville).  17:55-60. 
Guyette, W. A., R. J. Matusik, and J. M. Rosen. 1979. Prolactin mediated tran- 
scriptional and posttranscriptional regulation of casein gene expression. 
Cell.  17:1013-1023. 
Hennighansen, L. G., and A. E. Sippel.  1982. Characterization and cloning of 
the mRNAs specific for the lactating mouse mammary gland. Eur.  J. Bio- 
chem.  125:131-141. 
Hynes, N. E., D. Taverna, I. M. Harwerth, F. Ciardiello, D. S. Salomon, T. 
Yamamoto, and B. Groner. 1990. Epidermal growth factor receptor, but not 
c-erbB-2, activation prevents lactogenic hormone induction of the B-casein 
gene in mouse mammary epithelial cells. Mol.  Cell.  Biol.  10:4027--4034. 
Juergens, W. G., F. E. Stockdale,  Y. J. Topper, and J. J. Elias. 1965. Hormone 
dependent differentiation  of mammary  gland in vitro. Proc. Natl. Acad. Sci. 
USA. 54:629-634. 
Levine, J. F., and F. E. Stockdale.  1985. Cell-cell  interactions promote mam- 
mary epithelial  cell differentiation.  J.  Cell Biol.  100:1415-1422. 
Mack.inlay, A. C., and R. G. Wake. 1971. Kappa-casein  and its attack by rennin 
(chymosin). In Milk Proteins: Chemistry and Molecular Biology II.  H. A. 
McKenzie, editor. Academic Press, New York.  175-215. 
Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning. Cold 
Spring Harbor Laboratory, Cold Spring Harbor.  547 pp. 
Mieth, M., F,-D. Boehmer, R. Ball, B. Groner, and R. Grosse. 1990. Trans- 
forming growth factor-beta inhibits lactogenic hormone induction of beta- 
casein expression in HC11 mouse mammary epithelial  cells. Growth Fac- 
tors.  4:9-15. 
O'Hare, M., P. Kirwin, H. Razooki-Hasan, C. Wilde, D. A. White, and R. J. 
Mayer. 1986.  Secretion-coupled protein degradation: studies on mammary 
casein. Bloctffm.  Biophys.  Acta.  889:49-58. 
Oka, T., M. Yoshimura, S. Lavandero, K. Wada, and Y. Ohba. 1991. Control 
of growth and differentiation  of the mammary gland by growth factors. J. 
Dairy Sci.  74:2788-2800. 
Razooki Hasan, H., D. A. White, and R. J. Mayer. 1982. Extensive destruction 
of newly synthesized  casein in mammary  explants in organ culture. Biochem. 
J.  202:133-138. 
Rivera, E. M. 1971. M~ gland culture. In Methods of Mammalian Em- 
bryology.  J.  C.  Daniel,  Jr.,  editor.  Freeman and Co.,  San  Francisco. 
442-471. 
Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factor-betas. 
In Peptide Growth Factors and Their Receptors. M.  B. Sporn and A. B. 
Roberts, editors. Springer-Verlag, Heidelberg. 419-472. 
Robinson, S. D., G. B. Silberstein, A. B. Roberts, K. C. Flanders, and C. W. 
Daniel.  1991.  Regulated expression and growth inhibitory effects of trans- 
forming growth factor-beta isoforms in mouse mammary gland develop- 
ment. Development (Camb.).  113:867-878. 
Silberstein, G. B., and C. W. Daniel. 1987. Reversible inhibition of mammary 
gland growth by transforming growth factor-beta.  Science  (Wash.  DC). 
237:291-293. 
Stampfer, M. R., and J. C. Bartley.  1988.  Human mammary epithelial  cells 
in culture: differentiation  and transformation. In Breast Cancer: Cellular and 
Molecular Biology. M. E. Lippman, and R. B. Dickson, editors. Kluwer Ac- 
ademic Publishers, Boston/Dordrecht/London. 1-24. 
Terada, N., H. Wakimoto, and T. Oka. 1988. Regulation of milk protein syn- 
thesis of progesterone in cultured mouse mannnary gland. Steroid Biochem- 
istry.  29:99-104. 
Topper, Y. J. 1970. Multiple hormone interactions in the development of mam- 
mary gland in vitro. Recent Prog. Horm. Reg.  26:286-308. 
Topper, Y. J., and C. S. Freeman. 1980. Multiple hormone interactions in the 
development biology of the mammary gland. Physiol. Rev. 60:1049-1106. 
Valverius, E., D. Walker-Jones, S. E. Bates, M. R. Stampfer, R. Clark, P. 
McCormick, R. B. Dickson, and M. E. Lippman. 1989. Production of and 
responsiveness  to transforming growth factor beta in normal and oncogene 
transformed human mammary epithelial cells. Cancer Res. 49:6269-6274. 
Vonderhaar, B. K., and S. E. Ziska. 1989. Hormonal regulation of milk protein 
gene expression. Ann. Rev.  Physiol.  51:641-652. 
Wangh, D. F. 1971. Formation and structure of casein micelles. In Milk Pro- 
teins: Chemistry and Molecular Biology II.  H. A. McKenzie, editor. Aca- 
demic Press, New York. 3-85. 
Robinson et al.  1UF[3 Regulates Casein Synthesis  251 